Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.55 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | MPO | P05164 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 6/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.49 |
| ▸ | CA9 | Q16790 | 2/20 | 0.49 |
| ▸ | MAOA | P21397 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6926470 | 0.83 | HDAC3 (0.60) | ALDH1A1HPGDHDAC3HDAC1HDAC2 | |
| Methaniazide SCHEMBL29414958 | 0.82 | ALDH1A1 (0.55) | ALDH1A1HPGDHDAC3HDAC1HDAC2 | |
| Metazide SCHEMBL2109857 | 0.80 | ALDH1A1 (0.72) | ALDH1A1HPGDHDAC3HDAC1HDAC2 | |
| SCHEMBL2992964 | 0.77 | ALDH1A1 (1.00) | ALDH1A1HPGDKDM4EMPOCYP1A2 | |
| SCHEMBL2992165 | 0.77 | ALDH1A1 (0.67) | ALDH1A1HPGDKDM4EMPOCYP1A2 | |
| SCHEMBL2992612 | 0.77 | HDAC3 (0.70) | ALDH1A1HPGDHDAC3HDAC1HDAC2 | |
| SCHEMBL2998085 | 0.75 | ALDH1A1 (0.64) | ALDH1A1HPGDHDAC3HDAC1HDAC2 | |
| SCHEMBL2998521 | 0.75 | HDAC3 (0.68) | ALDH1A1HPGDHDAC3HDAC1HDAC2 | |
| SCHEMBL3001447 | 0.74 | HDAC3 (0.81) | ALDH1A1HDAC3HDAC1HDAC2KDM4E | |
| SCHEMBL14113829 | 0.74 | ALDH1A1 (0.62) | ALDH1A1HPGDHDAC3HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3880688-B1 | OLIGOSACCHARIDE PREPARATIONS AND COMPOSITIONS | DSM IP ASSETS BV (NL) | 2025-09-17 | — | — | EP | claimed |
| US-11655267-B2 | Oligosaccharide preparations and compositions | DSM IP ASSETS B.V. (NL) | 2023-05-23 | — | — | US | claimed |
| US-20210395284-A1 | OLIGOSACCHARIDE PREPARATIONS AND COMPOSITIONS | DSM IP ASSETS B.V. (NL) | 2021-12-23 | — | — | US | claimed |
| EP-3880688-A1 | OLIGOSACCHARIDE PREPARATIONS AND COMPOSITIONS | Midori USA, Inc. (US) | 2021-09-22 | — | — | EP | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| EP-1225916-A1 | COMPOSITIONS AND METHODS FOR CONTROLLED-RELEASE DELIVERY AND INCREASED POTENCY OF PHARMACEUTICALS VIA HYDROPHOBIC ION-PAIRING | University Technology Corporation (US) | 2002-07-31 | — | — | EP | claimed |
| WO-2001032218-A1 | COMPOSITIONS AND METHODS FOR CONTROLLED-RELEASE DELIVERY AND INCREASED POTENCY OF PHARMACEUTICALS VIA HYDROPHOBIC ION-PAIRING | UNIVERSITY TECHNOLOGY CORPORATION (US) | 2001-05-10 | — | — | WO | claimed |
| US-5596095-A | REMOVAL OF NEOPENTYL PROTECTING GROUPS AND REGENERATION OF PARENT DRUGS | PROCEPT, INC. (US) | 1997-01-21 | — | — | US | claimed |
| EP-4687916-A1 | OLIGOSACCHARIDE PREPARATION COUNTERACTING RESPIRATORY DISEASE EFFECT | DSM IP Assets B.V. (NL) | 2026-02-11 | — | — | EP | disclosed |
| EP-3880688-B1 | OLIGOSACCHARIDE PREPARATIONS AND COMPOSITIONS | DSM IP ASSETS BV (NL) | 2025-09-17 | — | — | EP | disclosed |
| EP-4613755-A1 | OLIGOSACCHARIDE PREPARATIONS AND COMPOSITIONS | DSM IP Assets B.V. (NL) | 2025-09-10 | — | — | EP | disclosed |
| US-12383570-B2 | Methods of selectively modulating gastrointestinal microbial growth | DSM IP ASSETS B.V. (NL) | 2025-08-12 | — | — | US | disclosed |
| WO-1996040156-A1 | DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS | ELIZANOR BIOPHARMACEUTICALS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| EP-0741570-A1 | METHOD FOR PREVENTING OR REDUCING PHOTOSENSITIVITY AND/OR PHOTOTOXICITY REACTIONS TO MEDICATIONS | G.D. SEARLE & CO. (US) | 1996-11-13 | — | — | EP | disclosed |
| WO-1996018609-A1 | FORMATION AND UTILITY OF SULFONIC ACID PROTECTING GROUPS | PROCEPT, INC. (US) | 1996-06-20 | — | — | WO | disclosed |
| WO-1995020387-A1 | METHOD FOR PREVENTING OR REDUCING PHOTOSENSITIVITY AND/OR PHOTOTOXICITY REACTIONS TO MEDICATIONS | G.D. SEARLE & CO. (US) | 1995-08-03 | — | — | WO | disclosed |